Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Advagraf to Envarsus conversion in stable lung transplant recipients
2015-005519-34Phase 2Completed
- Sponsor
- Vall d'Hebron Research Institute
- Start
- Feb 2016
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of tacrolimus in lung transplantation, sponsored by Vall d'Hebron Research Institute. Primary endpoint: Tacrolimus pharmacokinetic profile. Started Feb 2016; status: completed.
02
Drugs
tacrolimus
03
Conditions
lung transplantation
Beyond the preview
Go deeper on 2015-005519-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005519-34.